Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$116.17 USD
+0.71 (0.61%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $116.20 +0.03 (0.03%) 5:10 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Income Statements
Fiscal Year end for Zimmer Biomet Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7,394 | 6,940 | 7,836 | 7,025 | 7,982 |
Cost Of Goods | 2,084 | 2,020 | 2,341 | 2,128 | 2,253 |
Gross Profit | 5,310 | 4,920 | 5,495 | 4,896 | 5,730 |
Selling & Adminstrative & Depr. & Amort Expenses | 4,033 | 4,224 | 4,715 | 4,984 | 4,592 |
Income After Depreciation & Amortization | 1,278 | 696 | 780 | -88 | 1,138 |
Non-Operating Income | -9 | -128 | -153 | 25 | -5 |
Interest Expense | 201 | 165 | 208 | 212 | 227 |
Pretax Income | 1,067 | 404 | 418 | -274 | 906 |
Income Taxes | 42 | 112 | 16 | -137 | -226 |
Minority Interest | 1 | 1 | 1 | 2 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,025 | 290 | 402 | -137 | 1,132 |
Extras & Discontinued Operations | 0 | -59 | 0 | 0 | 0 |
Net Income (GAAP) | 1,024 | 231 | 402 | -139 | 1,132 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,229 | 1,916 | 1,864 | 1,590 | 2,214 |
Depreciation & Amortization (Cash Flow) | 952 | 1,219 | 1,084 | 1,678 | 1,076 |
Income After Depreciation & Amortization | 1,278 | 696 | 780 | -88 | 1,138 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 209.70 | 210.30 | 210.40 | 207.00 | 206.70 |
Diluted EPS Before Non-Recurring Items | 7.55 | 6.89 | 7.37 | 5.67 | 7.87 |
Diluted Net EPS (GAAP) | 4.88 | 1.10 | 1.91 | -0.67 | 5.47 |
Fiscal Year end for Zimmer Biomet Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,942.00 | 1,889.20 | 1,940.00 | 1,753.60 | 1,869.60 |
Cost Of Goods | 553.60 | 512.30 | 538.90 | 518.60 | 525.50 |
Gross Profit | 1,388.40 | 1,376.90 | 1,401.10 | 1,235.00 | 1,344.10 |
SG&A, R&D, and Dept/Amort Expenses | 1,037.20 | 1,111.00 | 1,047.10 | 968.40 | 1,014.40 |
Income After SG&A, R&D, and Dept/Amort Expenses | 351.20 | 265.90 | 354.00 | 266.60 | 329.70 |
Non-Operating Income | 2.00 | -0.10 | -19.60 | 3.80 | -1.20 |
Interest Expense | 51.10 | 50.70 | 50.30 | 51.10 | 51.60 |
Pretax Income | 302.20 | 215.10 | 284.50 | 219.20 | 276.80 |
Income Taxes | 59.10 | 42.30 | -135.20 | 56.40 | 66.90 |
Minority Interest | 0.30 | 0.40 | 0.70 | 0.20 | 0.20 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 243.10 | 172.80 | 419.70 | 162.70 | 209.90 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 242.80 | 172.40 | 419.00 | 162.70 | 209.70 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 206.40 | 206.20 | 208.60 | 210.00 | 209.90 |
Diluted EPS Before Non-Recurring Items | 2.01 | 1.94 | 2.20 | 1.65 | 1.82 |
Diluted Net EPS (GAAP) | 1.18 | 0.84 | 2.00 | 0.77 | 1.00 |